comparemela.com

Latest Breaking News On - Sifi spa - Page 1 : comparemela.com

SIFI Announces the Granting of a Second FDA Orphan Drug Designation for Polihexanide in Fungal Keratitis

/PRNewswire/ SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug.

United statesEdward hollandSebastiano giuffridaMaria grazia mazzoneJelle kleijnBusiness portfolio developmentHead of clinical developmentUniversity of cincinnatiEuropean medicines agencyDrug administrationResearch developmentOrphan drug designationExecutive directorPortfolio developmentDrug designationPrescription drug user fee act

SIFI Announces the Granting of a Second FDA Orphan Drug Designation for Polihexanide in Fungal Keratitis

/CNW/ SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug.

United statesEdward hollandSebastiano giuffridaMaria grazia mazzoneJelle kleijnBusiness portfolio developmentHead of clinical developmentUniversity of cincinnatiEuropean medicines agencyDrug administrationResearch developmentOrphan drug designationExecutive directorPortfolio developmentDrug designationPrescription drug user fee act

SIFI Announces Positive Topline Results of the Pivotal Phase III Study of Polihexanide for the Treatment of Acanthamoeba Keratitis

/PRNewswire/ SIFI, a leading international ophthalmic company, announced today that the pivotal Phase III study on polihexanide 0,08% monotherapy in adults.

John dartSebastiano giuffridaJelle kleijnUniversity college londonHead of clinical developmentInstitute of ophthalmologyEuropean medicines agencyFood drug administrationMarketing authorisation applicationCentralised procedureOrphan designated medicinal productsHonorary clinical professorFabrizio chinesDrug administrationSifi spa

vimarsana © 2020. All Rights Reserved.